SeqWright to Offer HairDx Test Service | GenomeWeb

NEW YORK (GenomeWeb News) – SeqWright today said that it will be the exclusive genetic testing provider for Pharmagenoma's HairDx test, which evaluates a patient's responsiveness to hair-loss treatment finasteride.

Houston-based SeqWright runs a clinical lab that offers genetic testing. The firm also offers genomics services including next-generation sequencing.

SeqWright said that the test would enable patients to determine if treatment benefit outweighs the potential side effects associated with finasteride.

Terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.